XSHE002511
Market cap1.15bUSD
Jan 14, Last price
6.61CNY
1D
2.64%
1Q
-5.97%
Jan 2017
-15.30%
IPO
-0.94%
Name
C&S Paper Co Ltd
Chart & Performance
Profile
C&S Paper Co.,Ltd manufactures and sells household paper products in Mainland China. The company primarily offers paper rolls, facial tissues, coreless rolls, tissue handkerchiefs, wipes, personal care products, baby diapers, cotton tissues, etc. It also sells medical devices, disposable medical products, disinfectants, medical face masks, general merchandise, kitchenware, sanitary ware, daily sundries, non-woven fabrics and products, polymer materials and products, wood pulp, and baby products, as well as provides warehousing services. The company provides products under the C&S, Sun, and Dolemi brands. C&S Paper Co.,Ltd was founded in 1979 and is based in Zhongshan, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 9,800,951 14.37% | 8,569,694 -6.34% | |||||||
Cost of revenue | 8,706,739 | 7,887,519 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 1,094,212 | 682,176 | |||||||
NOPBT Margin | 11.16% | 7.96% | |||||||
Operating Taxes | 31,510 | 60,545 | |||||||
Tax Rate | 2.88% | 8.88% | |||||||
NOPAT | 1,062,701 | 621,630 | |||||||
Net income | 332,744 -4.92% | 349,971 -39.77% | |||||||
Dividends | (104,128) | (128,503) | |||||||
Dividend yield | 0.81% | 0.72% | |||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 933,451 | 617,633 | |||||||
Long-term debt | 49,629 | 1,608 | |||||||
Deferred revenue | 98,420 | ||||||||
Other long-term liabilities | 134,799 | 1 | |||||||
Net debt | (1,911,146) | (737,248) | |||||||
Cash flow | |||||||||
Cash from operating activities | 1,241,990 | 391,693 | |||||||
CAPEX | (457,352) | ||||||||
Cash from investing activities | (828,927) | ||||||||
Cash from financing activities | 385,466 | 503,558 | |||||||
FCF | 2,005,969 | 176,497 | |||||||
Balance | |||||||||
Cash | 2,861,485 | 1,324,788 | |||||||
Long term investments | 32,742 | 31,702 | |||||||
Excess cash | 2,404,179 | 928,004 | |||||||
Stockholders' equity | 5,011,695 | 4,765,549 | |||||||
Invested Capital | 4,189,375 | 4,916,083 | |||||||
ROIC | 23.34% | 13.27% | |||||||
ROCE | 16.52% | 11.58% | |||||||
EV | |||||||||
Common stock shares outstanding | 1,279,786 | 1,296,189 | |||||||
Price | 10.00 -27.22% | 13.74 -17.77% | |||||||
Market cap | 12,797,861 -28.14% | 17,809,641 -19.30% | |||||||
EV | 10,895,727 | 17,337,746 | |||||||
EBITDA | 1,515,365 | 1,089,366 | |||||||
EV/EBITDA | 7.19 | 15.92 | |||||||
Interest | 33,438 | 6,012 | |||||||
Interest/NOPBT | 3.06% | 0.88% |